Legal Representation
Attorney
Allison L. Ko
USPTO Deadlines
Application History
13 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Dec 8, 2025 | RCSC | S | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | Loading... |
| Jun 7, 2025 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
| Jun 7, 2025 | GNSL | F | LETTER OF SUSPENSION E-MAILED | Loading... |
| Jun 7, 2025 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| May 22, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| May 22, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| May 22, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Mar 1, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Mar 1, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Mar 1, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Feb 22, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 21, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Aug 6, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Intravaginal drug delivery systems including compounds that facilitate delivery of pharmaceuticals; combination drug products, namely, pharmaceutical preparations incorporated within intervaginal rings configured for vaginal insertion to enable delivery of pharmaceutical preparations from the intravaginal ring
Class 042
Pharmaceutical drug development services; pharmaceutical drug delivery research services; research and development of new products in the nature of combination drug delivery; development of combination drug products for intravaginal delivery
Additional Information
Design Mark
The mark consists of the mark consists of the word Gaia with a stylized G that has a loop at the bottom left corner.
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
005
042